| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/23/2008 | EP1880733A1 Method for increasing longevity of a human being and animals |
| 01/23/2008 | EP1880732A1 Parathyroid hormone formulation |
| 01/23/2008 | EP1880726A1 Immune function modulating agents |
| 01/23/2008 | EP1879621A2 Active composition for treatment or prevention of problems related to a disturbance of the biological clock |
| 01/23/2008 | EP1879592A1 Use of inhibitors of steroid (testosterone) activity (i.a. estrogens) or antiandrogens) for treatment of substance correlated disorders like drug abuse |
| 01/23/2008 | EP1556354B1 Therapeutic piperazine derivates useful for treating pain |
| 01/23/2008 | EP1545619B1 Solution for ungual application |
| 01/23/2008 | EP1446117A4 Treatment of acute myeloid leukemia with indolinone compounds |
| 01/23/2008 | EP1436283B1 Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
| 01/23/2008 | EP1366175B1 Multifunctional protease inhibitors and their use in treatment of disease |
| 01/23/2008 | EP1347768B1 Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant argania spinosa |
| 01/23/2008 | EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 01/23/2008 | EP1330451B1 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 01/23/2008 | EP1322651B1 Bicyclic heteroaromatic compounds |
| 01/23/2008 | EP1311261B1 Medicaments for chemotherapeutic treatment of disease |
| 01/23/2008 | EP1268425B1 Carbamate caspase inhibitors and uses thereof |
| 01/23/2008 | EP1257547B1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 01/23/2008 | EP1237880B1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 01/23/2008 | EP1216032B1 Oral controlled release formulations |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | EP1175444B1 Amino-terminal modified parathyroid hormone (pth) analogs |
| 01/23/2008 | EP0986376B1 USE OF A FACTOR Xa INHIBITing oligosaccharide WITH A PLATELET ANTIAGGREGATING AGENT FOR TREATING ARTERIAL THROMBOSIS |
| 01/23/2008 | CN101111508A Spiroketal derivative and use thereof as diabetic medicine |
| 01/23/2008 | CN101111269A Composition for inhibiting expression of target gene |
| 01/23/2008 | CN101111266A Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 01/23/2008 | CN101111258A Emulsified composition for dilution and cancer vaccine composition |
| 01/23/2008 | CN101111247A Preventive or therapeutic agent for herpesvirus-related disease |
| 01/23/2008 | CN101108875A Growth hormone releasing peptides |
| 01/23/2008 | CN101108241A Medicament for improving pigling survival rate and method of manufacturing the same |
| 01/23/2008 | CN100363479C Method for preparing micrometer ginseng, pilose antler, pearl and pollen pini yang strengthening wine |
| 01/23/2008 | CN100363377C N heterocyclic substituted adenosine derivatives |
| 01/23/2008 | CN100363363C Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/23/2008 | CN100363362C Thiazole derivatives as NPY receptor antagonists |
| 01/23/2008 | CN100363015C Active hair gel |
| 01/23/2008 | CN100363005C Composite preparation for treatment of dementia |
| 01/23/2008 | CN100362995C CYP2A enzymes and their use in therapeutic and diagnostic method |
| 01/23/2008 | CN100362987C Particulate product comprising pantethine |
| 01/23/2008 | CN100362986C Dry powder inhalant composition |
| 01/23/2008 | CN100362926C Method for preparing milk contg. composite micron dendrobe for nourishing-yin, lowering blood-sugar and antifatigue |
| 01/23/2008 | CN100362925C Method for preparing sour milk contg. micron additives for tonifying-Yin and eliminating-fatigue |
| 01/22/2008 | US7320996 Administering to a cancer patient an indole-2-one derivative containing pyrrole ring as protein kinase inhibitor together with a cyclooxygenase inhibitor to treat the cancer |
| 01/22/2008 | US7320994 {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chloro-phenyl)-methanone; anxiety, depression, psychosis, and schizophrenia and other psychotic disorders; neurodegenerative disorders, multiple sclerosis and amyotrophic lateral sclerosis |
| 01/22/2008 | US7320991 Analogs of thalidomide as potential angiogenesis inhibitors |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320970 Low dose estrogen interrupted hormone replacement therapy |
| 01/22/2008 | US7320959 Transgenic aniomal nmodels; screening; administering peptide |
| 01/22/2008 | US7320880 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same |
| 01/22/2008 | US7320872 Genetically engineered nervous system cells for use in the treatment of alzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, trauma, brain, muscle, cardiovascular, vision , liver, kidney and pancreas disorders |
| 01/22/2008 | US7320870 Identifying a nucleic acid sequence encoding a lacritin receptor by contacting transfected cells with lacritin and detecting calcium signaling |
| 01/22/2008 | US7320869 Antibodies to Chemokine Alpha-5 |
| 01/22/2008 | US7320804 Orally administering ferrous sulfate for inhibiting dry cough induced by angiotensin-converting enzyme inhibitors |
| 01/22/2008 | US7320785 Compositions and methods for modulation of DARPP-32 phosphorylation |
| 01/22/2008 | CA2490638C Combination therapy wherein a serotonin reuptake inhibitor is used |
| 01/22/2008 | CA2420999C 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 01/22/2008 | CA2408251C Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 01/22/2008 | CA2404120C Use of bradycardiac agents in the treatment of myocardial diseases accompanied by hypertrophy and new drug combinations |
| 01/22/2008 | CA2368348C Biodegradable, injectable oligomer-polymer composition |
| 01/22/2008 | CA2333322C Nitric oxide synthase inhibitors |
| 01/22/2008 | CA2312431C New compounds |
| 01/22/2008 | CA2293553C Aminooxyamide tricyclic inhibitors of farnesyl-protein transferase |
| 01/22/2008 | CA2283101C Quinoline leukotriene antagonists |
| 01/22/2008 | CA2281721C Phthalazines with angiogenesis inhibiting activity |
| 01/22/2008 | CA2272598C A process for the preparation of 4-(des-dimethylamino)-tetracyclines |
| 01/17/2008 | WO2008008814A2 Tissue transplantation compositions and methods |
| 01/17/2008 | WO2008008513A2 Combination treatments |
| 01/17/2008 | WO2008007780A1 Pentadienamide derivative |
| 01/17/2008 | WO2008007766A1 Crystal of benzoxadiazole derivative |
| 01/17/2008 | WO2008007728A1 Oral preparation in the form enclosed in lipid membrane structure, and fatigue-ameliorating agent comprising coenzyme a as active ingredient |
| 01/17/2008 | WO2008007664A1 Bicyclic heterocyclic compound and use thereof |
| 01/17/2008 | WO2008007661A1 Tricyclic heterocyclic compound and use thereof |
| 01/17/2008 | WO2008007113A2 Pharmaceutical combinations |
| 01/17/2008 | WO2008006511A2 Use of fosfluridine tidoxil (ft) for the treatment of intraepithelial proliferative diseases |
| 01/17/2008 | WO2007048645A3 Protection of oxidizable agents |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | US20080015347 Kind Of Fusion Protein, Gene Encoding It, Expression Method And Use Thereof |
| 01/17/2008 | US20080015265 Methods of treating obesity using satiety factors |
| 01/17/2008 | US20080015261 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function |
| 01/17/2008 | US20080015255 Pharmaceutical Compositions Based on Fluorinated Sulphamides and Sulphinimides |
| 01/17/2008 | US20080015249 Cancer treatment compositions and method using natural plant essential oils |
| 01/17/2008 | US20080015242 Use of N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydroxyethyl]phenyl]methanesulfonamide or salt for treating diabetes, obesity, hyperlipidemia and urinary incontinence; drug interaction side effect reduction |
| 01/17/2008 | US20080015224 Nitroxide superoxide dismutase mimetics to treat extracellular superoxide dismutase deficiencies |
| 01/17/2008 | US20080015223 Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto |
| 01/17/2008 | US20080015215 Diamine derivatives |
| 01/17/2008 | US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase |
| 01/17/2008 | US20080015194 Methods and compositions of targeted drug development |
| 01/17/2008 | US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015180 Methods and compositions for treating amyloid-related diseases |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015162 Compounds and methods for modulating gene expression |
| 01/17/2008 | US20080015161 RNAi modulation of TGF-beta and therapeutic uses thereof |
| 01/17/2008 | US20080015150 Peptides and Derivatives Thereof Showing Cell Attachment, Spreading and Detachment Activity |
| 01/17/2008 | US20080015148 Suitable for lyophilization, protein capable of binding and inhibiting the biological action of IL-1,histidine, glycine, arginine, sucrose, stability; resistant to degradation, aggregation, oxidation, and other degenerative processes while in the freeze dried state |
| 01/17/2008 | US20080015139 Soluble virus-specific T-cell receptor compositions |
| 01/17/2008 | US20080014292 Composition for treating and/or preventing periodontal disease |
| 01/17/2008 | US20080014291 Process for the Production of Multi-Component Mineral Substance Preparations |
| 01/17/2008 | US20080014262 Rapidly disintegrating tablet containing polyvinyl alcohol |
| 01/17/2008 | US20080014246 Methods and compounds for controlled release of recombinant parvovirus vectors |